Inflation Reduction Act (IRA)

Featured Resources

See All in Inflation Reduction Act (IRA)

IRA Resource Center

AMCP Member Advocates
On
The Inflation Reduction Act (IRA) was signed into law on Aug. 16, 2022. Many questions remain about the implementation of this law, which will be done through agency guidance, program instruction, agreements between CMS and drug manufacturers, and notice-and-comment rulemaking. This resource center provides resources to help answer those questions and provide additional information.
JMCP Mention: Negotiated Drug Prices Will Help Medicare Beneficiaries; Unclear If And By How Much Government Saves And Industry Loses
AMCP In The News Forbes.com

Negotiated Drug Prices Will Help Medicare Beneficiaries; Unclear If And By How Much Government Saves And Industry Loses

Because most prescription drugs selected for negotiation are highly rebated and discounted—prior to the federal government negotiations—comparisons of MFPs with list prices are somewhat misleading. Many of the ten drugs chosen already had significant rebates, in some cases as high as 68% off of the wholesale acquisition cost.
Legislation & Regulation, Inflation Reduction Act (IRA)
JMCP Bloomberg Article: Drugmakers, Medicare Conclude Talks to Slash Spiraling Costs
AMCP In The News Bloomberg Law

Drugmakers, Medicare Conclude Talks to Slash Spiraling Costs

Hernandez co-authored a June study in the Journal of Managed Care & Specialty Pharmacy (JMCP) on price benchmarks for selected drugs and their therapeutic alternatives, which concluded different negotiation scenarios for the first 10 drugs. If a drug has a therapeutic alternative, that likely guided the initial price offer from the CMS.
Legislation & Regulation, Inflation Reduction Act (IRA)